1 |
Alanazi1, F.K., Alsarra, I.A., Haq, N., Radwan, A.A. and Shakeel, F. (2014), "Potential of lipid nanoemulsion for drug delivery of cholesteryl-hexahydrophthaloyl-5-fluorouracil", J. Drug Deliv. Sci. Technol., 24(5), 459-463.
DOI
ScienceOn
|
2 |
Anand, D., Dowell, J.A., Sancho, A.R. and Wolf, W. (2000), "Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors", Adv. Drug Deliv. Rev., 41(1), 111-126.
DOI
ScienceOn
|
3 |
Bai, M.Y. and Liu, S.Z. (2014), "Simple and general method for preparing antibody-PEG-PLGA sub-micron particles using electrospray technique: An in vitro study of targeted delivery of cisplatin to ovarian cancer cells", Colloid. Surf. B: Biointerfaces, 117, 346-353.
DOI
|
4 |
Blanco, E., Gao, J. and Weinberg, B.D. (2008), "Polymer implants for intratumoral drug delivery and cancer therapy", J. Pharma Sci., 97(5), 1681-1702.
DOI
ScienceOn
|
5 |
Chan, E.C., Chen, J.K., Chi, P.S., Lin, S.S., Liu, S.J. and Ueng, S.W.N. (2007), "Novel solvent-free fabrication of biodegradable poly-lactic-glycolic Acid (PLGA) capsules for antibiotics and rhBMP-2 delivery", Int. J. Pharma., 330(1-2), 45-53.
DOI
ScienceOn
|
6 |
Chung, Y.I., Kim, J.C., Kim, K., Kim, Y.H., Kwon I.C., Lee, S.Y. and Tae, G. (2010), "The effect of surface functionalization of PLGA nanoparticles by heparin-or chitosan-conjugated Pluronic on tumor targeting", J. Control. Release, 143(3), 374-382.
DOI
ScienceOn
|
7 |
Conchita, Tros de Ilarduya, Daniel, M., Inigo, N., Maria, J.G. and Sara, Z. (2010), "Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice", Eur. J. Pharmaceutics Biopharmaceutics, 74(2), 265-274.
DOI
ScienceOn
|
8 |
Crawford, J., Dale, D.C. and Lyman, G.H. (2004), "Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management", Cancer, 100(2), 228-237.
DOI
ScienceOn
|
9 |
Di, W., Duan, Y., Gu, L., Liu, P., Qiu, L., Sun, Y., Wang, Y. and Zhu, M. (2013), "Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice", Biomater., 34(16), 4068-4077.
DOI
ScienceOn
|
10 |
Einhorn, L.H. (1990), "Treatment of testicular cancer: a new and improved model", J. Clin. Oncol., 8(11), 1777-1781.
DOI
|
11 |
El-Kareh, A.W. and Secomb, T.W. (2000), "A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells", Neoplasia, 2(4), 325-338.
DOI
|
12 |
Gillams, A.R. (2005), "Image guided tumour ablation", Cancer Imag., 5(1), 103-109.
DOI
|
13 |
Harkin, D.P., Johnston, P.G. and Longley, D.B. (2003), "5-fluorouracil: mechanisms of action and clinical strategies", Natl. Rev. Cancer, 3(5), 330-338.
DOI
ScienceOn
|
14 |
Kau, Y.C., Liu, K.S., Liu, S.J., Peng, Y.J. and Wen, C.W. (2010), "Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin and dexamethasone-An in vivo study", J. Biomed. Mater. Res. Part A, 94(2), 426-432.
|
15 |
Wallace, K.B. (2003), "Doxorubicin-induced cardiac mitochondrionopathy", Pharmacol Toxicol, 93(3), 105-115.
DOI
ScienceOn
|
16 |
Middleton, J.C. and Tipton, A.J. (2000), "Synthetic biodegradable polymers as orthopedic devices", Biomater., 21(23), 2335-2346.
DOI
ScienceOn
|
17 |
Peter, G.J. and Van Groeningen, C.J. (1991), "Clinical relevance of biochemical modulation of 5-fluorouracil", Ann. Oncol., 2(7), 469-480.
DOI
|
18 |
Sanjeeb, K.S. and Sarbari, A. (2011), "PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect", Adv. Drug Deliv. Rev., 63(3), 170-183.
DOI
ScienceOn
|